 |
|
|
Aug '05 |
Aug '06 |
Aug '07 |
Aug '08 |
Aug '09 |
|
| Sales Turnover |
430.63 |
491.50 |
495.32 |
501.49 |
592.96 |
| Other Income |
29.10 |
35.55 |
320.38 |
64.74 |
56.39 |
| Total Income |
459.73 |
527.05 |
815.70 |
566.23 |
649.35 |
| Total Expenses |
347.20 |
378.49 |
379.72 |
393.95 |
467.27 |
| Operating Profit |
83.43 |
113.01 |
115.60 |
107.54 |
125.69 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-19.95 |
-5.69 |
-14.75 |
209.30 |
-6.49 |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
112.53 |
148.56 |
435.98 |
172.28 |
182.08 |
| Interest |
0.15 |
0.02 |
-- |
-- |
-- |
| PBDT |
92.43 |
142.85 |
421.23 |
381.58 |
175.59 |
| Depreciation |
9.87 |
9.98 |
8.04 |
4.68 |
4.14 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
82.56 |
132.87 |
413.19 |
376.90 |
171.45 |
| Tax |
31.81 |
44.14 |
96.33 |
108.01 |
60.00 |
| Net Profit |
50.75 |
88.73 |
316.86 |
268.89 |
111.45 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
17.01 |
29.74 |
106.19 |
90.11 |
37.35 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
29.84 |
29.84 |
29.84 |
29.84 |
29.84 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
10.00 |
10.00 |
10.00 |
10.00 |
10.00 |
|
|
|
|
| Source : Religare Technova |
| Explore Pfizer connections |
|
